Results 121 to 130 of about 1,134,527 (163)

Acatalasemia and type 2 diabetes mellitus

Orvosi Hetilap, 2015
The catalase enzyme decomposes the toxic concentrations of hydrogen peroxide into oxygen and water. Hydrogen peroxide is a highly reactive small molecule and its excessive concentration may cause significant damages to proteins, deoxyribonucleic acid, ribonucleic acid and lipids. Acatalasemia refers to inherited deficiency of the catalase enzyme.
László, Góth, Teréz, Nagy, Miklós, Káplár   +2 more
openaire   +2 more sources

Type 2 Diabetes Mellitus in Youth

The Journal of School Nursing, 2003
In the United States, the incidence of type 2 diabetes mellitus (DM) in children and adolescents has been increasing at an alarming rate. Early recognition and intervention can delay the onset of type 2 DM and prevent the long-term complications. School nurses have an essential role in implementing the American Diabetes Association (ADA) recommended ...
Jill L, Quarry-Horn, Barbara J, Evans, James R, Kerrigan   +2 more
openaire   +2 more sources

Liraglutide for type 2 diabetes mellitus

Expert Opinion on Biological Therapy, 2011
Prevalence of type 2 diabetes mellitus (T2DM) is increasing. Management of this condition and minimizing the cardiovascular risks associated with it poses a significant burden on healthcare resources across the world. Currently available therapeutic agents are effective in glycemic management; however, the majority of these are associated with ...
Kela, R, Khunti, K, Davies, MJ
openaire   +3 more sources

The Prevention of Type 2 Diabetes Mellitus

Endocrinology and Metabolism Clinics of North America, 2005
With a worldwide pandemic of type 2 diabetes upon us, it is imperative that effective and practical preventive strategies be developed for this disease which, once established, carries with it excess morbidity and mortality. This article reviews recently published data on the prevention of type 2 diabetes and compares the demonstrated effectiveness of ...
Silvio E, Inzucchi, Robert S, Sherwin
openaire   +2 more sources

Type 2 Diabetes Mellitus in Children

Endocrine Practice, 1998
To provide an overview of type 2 diabetes in children and discuss short-term and long-term management strategies.We review the distinction among various types of diabetes mellitus as they apply to children. In addition, we discuss determining the precise diagnosis between the two major variants--type 1 and type 2 diabetes--and clinical management of ...
J H, Pohl, J A, Greer, K S, Hasan
openaire   +2 more sources

Dyslipidemia in type 2 diabetes mellitus

Current Diabetes Reports, 2007
Cardiovascular disease is a significant cause of morbidity and mortality in patients with diabetes mellitus (DM). DM is now recognized as a risk equivalent for coronary heart disease. The lipid profile in patients with type 2 DM is characterized by elevated triglycerides, low levels of high-density lipoprotein cholesterol, and small dense low-density ...
Ramprasad, Gadi, Frederick F, Samaha
openaire   +2 more sources

Exercise for type 2 diabetes mellitus

Cochrane Database of Systematic Reviews, 2006
Exercise is generally recommended for people with type 2 diabetes mellitus. However, some studies evaluate an exercise intervention including diet or behaviour modification or both, and the effects of diet and exercise are not differentiated. Some exercise studies involve low participant numbers, lacking power to show significant differences which may ...
Thomas, Diana, Elliot, Elizabeth, Naughton, Geraldine   +2 more
openaire   +4 more sources

Dyslipidemia in type 2 diabetes mellitus

Nature Reviews Endocrinology, 2009
Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.
openaire   +2 more sources

Pathogenesis of type 2 diabetes mellitus

Experimental and Clinical Endocrinology & Diabetes, 2001
Type 2 diabetes mellitus is a heterogeneous disorder with genetic and acquired components. It is primarily due to impaired insulin secretion in that individuals with genetically impaired beta cell function cannot increase their insulin release sufficiently to compensate for insulin resistance.
J, Dostou, J, Gerich
openaire   +2 more sources

Lixisenatide for type 2 diabetes mellitus

Expert Opinion on Investigational Drugs, 2011
Type 2 diabetes mellitus (T2DM) is an increasing health problem worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists are an expanding drug class that target several of the pathophysiological traits of T2DM. Lixisenatide is a GLP-1 receptor agonist in development for once-daily treatment of T2DM.Pharmacological, preclinical and clinical evidence
Christensen, Mikkel, Knop, Filip K, Vilsbøll, Tina, Holst, Jens Juul   +3 more
openaire   +3 more sources